(Q36556317)

English

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

scientific article published on 3 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ismene L Petrakis

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Charla Nich

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Elizabeth Ralevski

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

3 August 2006

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Schizophrenia Bulletin

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

644-654

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Treatment compliance in patients with comorbid psychiatric and substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Treatment of alcohol-dependent outpatients with acamprosate: a clinical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Neurobiology of addiction. Toward the development of new therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

The effects of clozapine on aggression and substance abuse in schizophrenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Craving for alcohol: findings from the clinic and the laboratory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Acamprosate in alcohol dependence: how does it work?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Antabuse contracts for married alcoholics and their spouses: a method to maintain antabuse ingestion and decrease conflict about drinking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

'Catatonia' due to disulfiram toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Random regression models for multicenter clinical trials data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Naltrexone in the treatment of alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

30 September 2017

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

Naltrexone utility in depressed alcoholics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

Spouse contracting to increase antabuse compliance in alcoholic veterans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

Adjunctive desipramine in the treatment of cocaine abusing schizophrenics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

Maintaining disulfiram ingestion among outpatient alcoholics: a security-deposit contingency contracting procedure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

28 June 2018

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders.

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Preclinical and clinical studies on naltrexone: what have they taught each other?

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Targeted naltrexone for early problem drinkers

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Naltrexone treatment for alcohol dependence

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Selective and enduring deficits in spatial learning after limited neonatal binge alcohol exposure in male rats

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Oxcarbazepine for mood disorders

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBL010

21 January 2018

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

21 September 2018

Disulfiram treatment for alcoholism in severe mental illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

21 September 2018

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

21 September 2018

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

21 September 2018

Substance abuse in schizophrenia: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

21 September 2018

Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2632271

21 September 2018

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance with disulfiram treatment of alcoholism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased substance use in chronically psychotic patients treated with clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of comorbid substance abuse with clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alcohol dependence and hospitalization in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone in the treatment of alcohol dependence

1 reference

https://pubmed.ncbi.nlm.nih.gov/16887890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/SCHBUL/SBL010

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36556317&oldid=1637787769"